Ranolazine, a partial fatty acid oxidation inhibitor, improves left ventricular function in dogs with heart failure through an increase in myocardial efficiency

✍ Scribed by M.P. Chandler; W.C. Stanley; H. Morita; G. Suzuki; O. Nass; B. Blackburn; A. Wolfe; H.N. Sabbah

• Book ID: 117141571
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 148 KB
• Volume: 33
• Category: Article
• ISSN: 0022-2828
• DOI: 10.1016/s0022-2828(01)90629-7